Table 3 Pleural fluid characteristics of the studied patients
From: Assessment of diaphragmatic role in dyspneic patients with pleural effusion
No.= 30 | ||
|---|---|---|
Pleural fluid chemistry | Exudate | 29 (96.7%) |
Transudate | 1 (3.3%) | |
CXR degree of effusion (1–5) | Mean± SD | 3.90 ± 0.66 |
Range | 3–5 | |
Effusion side | Right | 13 (43.3%) |
Left | 17 (56.7%) | |
Cause of effusion | Adenocarcinoma | 12 (40.0%) |
Metastatic adenocarcinoma | 7 (23.3%) | |
TB pleural effusion | 3 (10.0%) | |
Para pneumonic effusion | 3 (10.0%) | |
Mesothelioma | 2 (6.7%) | |
NHL | 1 (3.3%) | |
Empyema | 1 (3.3%) | |
HF | 1 (3.3%) | |
Effusion duration (months) | Median (IQR) | 2 (1–4) |
Range | 0.33–9 | |
Reason of stopping tapping | Chest pain | 11 (36.7%) |
Cough | 9 (30.0%) | |
Chest pain & cough | 5 (16.7%) | |
Effusion decreased | 4 (13.3%) | |
Vasovagal attack | 1 (3.3%) | |
Amount drained (ml) | Mean±SD | 1263.33 ± 341.88 |
Range | 1000–2000 | |